Anticoagulation With Otamixaban and Ischemic Events in Non-ST-Segment Elevation Acute Coronary Syndromes The TAO Randomized Clinical Trial


Steg P. G., Mehta S. R., Pollack C. V., Bode C., Cohen M., French W. J., ...More

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, vol.310, no.11, pp.1145-1155, 2013 (SCI-Expanded) identifier identifier identifier

Abstract

IMPORTANCE The optimal anticoagulant for patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) managed with an invasive strategy remains controversial.